Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita

Journal of Autoimmunity

Volumn 68, Issue , 2016, Pages 14-22

  Ellebrecht, Christoph T ^a,b   Srinivas, Girish ^c   Bieber, Katja ^b   Banczyk, David ^b   Kalies, Kathrin ^b   Künzel, Sven ^c   Hammers, Christoph M ^b   Baines, John F ^c   Zillikens, Detlef ^b   Ludwig, Ralf J ^b   Westermann, Jürgen ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LÜBECK   (Germany)

^c MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

Author keywords

Autoantibodies; Autoimmune bullous disease; Host microbiome interaction

Indexed keywords

AUTOANTIBODY; CXCL1 CHEMOKINE; GLYCOPROTEIN P 15095;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; IMMUNIZATION; INNATE IMMUNITY; LYMPH NODE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FLORA; SWISS JAMES LAMBERT MOUSE; T LYMPHOCYTE; TISSUE INJURY; ANIMAL; DISEASE MODEL; DISEASE PREDISPOSITION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METAGENOMICS; MICROBIOLOGY; MICROFLORA; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SKIN;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; IMMUNIZATION; METAGENOMICS; MICE; MICROBIOTA; ROC CURVE; SKIN;

EID: 84960087196     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.08.007     Document Type: Article

References (47)

1. Woodley D.T., et al. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N. Engl. J. Med. 1984, 310:1007-1013.
2. Woodley D.T., Burgeson R.E., Lunstrum G., Bruckner-Tuderman L., Reese M.J., Briggaman R.A. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J. Clin. Investig. 1988, 81:683-687.
3. Ludwig R.J., Zillikens D. Pathogenesis of epidermolysis bullosa acquisita. Dermatol. Clin. 2011, 29:493-501.
4. Hashimoto T., Ishii N., Ohata C., Furumura M. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease. J. Pathol. 2012, 228:1-7.
5. Sitaru C., et al. Autoantibodies to type VII collagen mediate fcγ-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am. J. Pathol. 2002, 161:301-311.
6. Recke A., et al. Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J. Autoimmun. 2010, 34:435-444.
7. Sitaru C., et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J. Clin. Investig. 2005, 115:870-878.
8. Woodley D.T., et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J. Investig. Dermatol. 2005, 124:958-964.
9. Woodley D.T., et al. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J. Investig. Dermatol. 2006, 126:1323-1330.
10. Kasperkiewicz M., et al. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J. Pathol. 2012, 228:8-19.
11. Sitaru C., et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J. Immunol. 2006, 177:3461-3468.
12. Hammers C.M., et al. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. J. Immunol. 2011, 187:5043-5050.
13. Ludwig R.J., et al. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J. Investig. Dermatol. 2011, 131:167-176.
14. Naik S., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
15. Fahlén A., Engstrand L., Baker B.S., Powles A., Fry L. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch. Dermatol. Res. 2012, 304:15-22.
16. Conlan S., Kong H.H., Segre J.A. Species-level analysis of DNA sequence data from the NIH human microbiome project. PloS One 2012, 7:e47075.
17. Li Ning, Mao Debin, Lü Shouqin, Tong Chunfang, Zhang Yan, Long Mian Distinct binding affinities of Mac-1 and LFA-1 in neutrophil activation. J. Immunol. 2013, 190:4371-4381.
18. MacLeod A.S., Havran W.L. Functions of skin-resident γδ T cells. Cell. Mol. Life Sci. 2012, 68:2399-2408.
19. Nimmerjahn F., et al. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005, 23:41-51.
20. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
21. Berndt B.E., et al. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J. Immunol. 2007, 179:6255-6262.
22. Becker S., et al. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 1994, 266:278-286.
23. Iida N., Gary G. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Mol. Cell. Biol. 1990, 10:5596-5599.
24. Chintakuntlawar A.V., Chodosh J. Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J. Interferon Cytokine Res. 2009, 29:657-666.
25. Hayashida K., Parks W.C., Park P.W. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 2009, 114:3033-3043.
26. Vieira S.M., et al. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br. J. Pharmacol. 2009, 158:779-789.
27. Nancy A.-L., Yehuda S. Prediction and prevention of autoimmune skin disorders. Arch. Dermatol. Res. 2009, 301:57-64.
28. Knip M., et al. Prediction of type 1 diabetes in the general population. Diabetes Care 2010, 33:1206-1212.
29. Scofield R.H. Autoantibodies as predictors of disease. Lancet 2004, 363:1544-1546.
30. Srikanta S., et al. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann. Intern. Med. 1983, 99:320-326.
31. Srikanta S., et al. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N. Engl. J. Med. 1983, 308:322-325.
32. Iwata H., et al. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. J. Immunol. 2013, 191:2978-2988.
33. Hirose M et al, The allosteric CXCR1/2 inhibitor DF2156A improves experimental epidermolysis bullosa acquisita, J. Genet. Syndr. Gene Ther. doi:10.4172/2157-7412.S3-005.
34. Naik S., et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015, 520:104-108.
35. Abrahamsson T.R., et al. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 2012, 129:434-440.
36. Hanski I., et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:8334-8339.
37. Kamradt T., Mitchison N.A. Tolerance and autoimmunity. N. Engl. J. Med. 2001, 344:655-664.
38. Schierwagen C., et al. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J. Pharmacol. Methods 1990, 23:179-186.
39. Barthelmann J., et al. The protective Th1 response in mice is induced in the T-cell zone only three weeks after infection with Leishmania major and not during early T-cell activation. Med. Microbiol. Immunol. 2012, 201:25-35.
40. Kalies K., et al. T cell zones of lymphoid organs constitutively express Th1 cytokine mRNA: specific changes during the early phase of an immune response. J. Immunol. 2006, 176:741-749.
41. Kalies K., et al. Nonoverlapping expression of IL10, IL12p40, and IFNgamma mRNA in the marginal zone and T cell zone of the spleen after antigenic stimulation. J. Immunol. 2008, 180:5457-5465.
42. Rausch P., et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 ( Secretor ) genotype. Proc. Natl. Acad. Sci. U. S. A. 2011, 22(108):19030-19035.
43. Edgar R.C., et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011, 27:2194-2200.
44. Wang Q., et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73:5261-5267.
45. Caporaso J.G., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010, 7:335-336.
46. Dixon P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 2003, 14:927-930.
47. Anderson M.J., Willis T.J. Canonical analysis of principal coordinates: a useful method of constrained ordination for ecology. Ecology 2003, 84:511-525.